Biopharma PEG supplies polyethylene glycol (PEG) derivatives, monodisperse PEGs, custom PEG derivative synthesis and PEGylation services worldwide, from R&D through GMP commercial quantities, for preclinical, clinical trials, and commercial products for pharma, biotech, medical devices, and diagnostics
Comprehensive Support for GLP-1 Therapy Manage Side Effects &
Research Use Only
For example, while the SUSTAIN-6 study included patients with proliferative DR (PDR) and diabetic macular edema (DME), other CVOTs, such as PIONEER 6, did not
The tradeoff is variability in product formulation and the fact that compounded GLP-1s are not FDA-approved brand products
For those exploring a non-injection alternative to GLP-1 medications, oral semaglutide has emerged as a promising option